31 lug 2015
FDA Approves Sonidegib for Treatment of Locally Advanced Basal Cell Carcinoma
The US Food and Drug Administration (FDA) approved sonidegib (Odomzo) to treat patients with locally advanced basal cell carcinoma that has recurred following surgery or radiation therapy, or who are not candidates for surgery or radiation therapy
